TMS Therapy For Depression
in Saline, MI

Reach Us Now for an Evaluation
You Can Live Without Depression

Drug resistant Major Depressive Disorder (MDD) and Obsessive Compulsive Disorder (OCD) can now be treated by non-pharmacological, non-sedating, out-patient Transcranial Magnetic Stimulation (TMS) Therapy1.
TMS is FDA approved and proven to be effective, giving hope to patients suffering from these debilitating conditions.
You have hope, take the next step:

Center For Family Psychiatry
& TMS Therapy
Saline, MI

Established since 2004, we are Greater Ann Arbor and Washtenaw County’s trusted mental health provider and offer advanced TMS Therapy For Depression and OCD.

What is TMS?

Transcranial Magnetic Stimulation, or TMS, works by excitation of neurons in identified cortical regions of the brain by highly controlled and precisely delivered magnetic pulses. These magnetic pulses are generated by a magnetic coil placed on the scalp by FDA approved equipment, and travel as magnetic field waves through the cranium (without any incision or “invasion”) into a targeted part of the brain for desired therapeutic effects.

TMS Therapy for Persistent Depression and OCD

Studies show that in Depression patients the dorsolateral prefrontal cortex (DLPFC) of the brain can be hypo-active on the left side and can be hyper-active on the right side. With TMS Therapy the DLPFC is excited by the magnetic pulses into activation which is believed to propagate further into the deeper target areas of the brain where mood modulation is believed to occur. Further, clinical hypothesis is that there can be inhibitory effects on some of the hyper-active areas. Thus, TMS therapy can modulate the areas of the brain to bring normalization of activity levels. The video below depicts an outline of the TMS treatment process for depression treatment.

Similarly, studies on Obsessive Compulsive Disorder (OCD) typically show hypoactivity in the dorsomedial regions of the brain. In such cases, the magnetic waves delivered by TMS Therapy are believed to excite the neuronal connections and bring the dorsomedial region to a balanced normal level, alleviating OCD symptoms.

TMS Therapy for persistent Major Depressive Disorder (MDD) was approved by the FDA in 2008. Given the high effectiveness and lower risks of TMS Therapy, it is also recommended by the American Psychiatric Association for treating MDD patients who have not had adequate response to two or more trials of adequate dosing and duration of anti-depressants.

TMS Clinical Background

TMS was first used in 1984 by Anthony Barker and has since evolved as a leading frontier in fighting Depression and OCD. Studies show that after the completion of the acute phase of TMS Therapy up to 75% patients report a reduction in depression. Further, 66% reported a reduction in depression score after a 4-week treatment period. Most encouragingly, nearly 30% of treated patients may enter remission – it is important to note that patients enrolled in these studies after multiple traditional antidepressant medications had failed to provide adequate relief from active persistent symptoms.

The successes of TMS Therapy in drug resistant MDD and OCD have been noted by health insurance companies and mental health service providers. TMS Therapy is now being provided at major hospitals and qualified mental health clinics worldwide with most insurance companies covering the treatment.

CFFP TMS Therapy Practice

At the Center for Family Psychiatry, in Saline, MI, TMS treatment is provided by fully trained and qualified practitioners under the supervision of the Medical Director, Dr. Ravi Kirbat. We use an FDA approved TMS machine that is proven to be well tolerated and highly effective. The equipment centers around a comfortable chair, similar looking to a dentist’s chair, with a small magnetic coil held in an overhead arm attached to main control and power unit. Patients are semi-inclined through the treatment; they remain awake and feel a series of tapping sensations on the frontal area of the skull with a clicking noise. They are able to engage in normal sedentary activities such as listening to music. After the treatment, patients continue their normal activities of the day with no cognitive or physical changes. While the occurrences of side effects such as initial headaches and scalp sensitivity can occur, they are usually temporary or well tolerated. The most serious risk is of seizures which is very low incidence and is consistent with the seizure risk with some antidepressant medications. Patients are encouraged to read about these and will be discussed in detail on initial assessments.

In summary, TMS treatment is:

  1. Non-invasive, non-sedating and does not affect memory and cognitive functions; no insertions required and no disruption to normal activity
  2. Can be an adjunct or stand-alone treatment based on particular patient cases
  3. Covered by most insurance plans – we assist patients with the reimbursement and financing process.
  4. Provided by qualified practitioners
  5. Easily accessible facility within the greater Ann Arbor tri-county area with ample free parking at our comfortable and handicap accessible offices

It is important to state that, like any other treatment, individual results vary and that patients should diligently research and discuss the potential benefits and side effect risks with their practitioners. Take the next step towards hope for yourself or your loved one: Please click one of the buttons below to learn more or reach us for a review of your case

Our TMS Services

Our Other Services

We Work With Major Insurance Plans

BlueCross BlueShield PPO, Medicare Plus Blue and Federal Plans
Blue Care Network HMO Plans
Varies by Provider
Most Medicare Plans
Varies By Provider
Non Medicaid Plans
Medication Management only
Medication Management only
Blue Cross Complete
Dr. Ravi Kirbat, Founder & Medical Director

TMS Results at the clinic have been impressive!

We are glad to bring you this excerpt from recent press release (May 31, 2022). You can read the detailed press release on our blogs page here:

β€œSince starting to operate CFFP over 17 years ago, we have always had a subset of depression and OCD patients who were non-responsive to traditional pharmacological treatments. More so, in the last couple of years with the pandemic related stressors, there has been a substantial increase in acuity of such patients, which is frustrating for the patients and practitioners. We have been following developments in a number of modalities for attempting to provide relief to our partially responsive or non-responsive patients,” said Dr. Ravi S. Kirbat, MD, Medical Director of CFFP.

…β€œTo address the growing numbers of treatment resistant mood disorder cases, CFFP extended its treatment line to include FDA-approved TMS Therapy in early 2021. TMS treatment results at the clinic have been impressive, with response rates ranging from 60 to 70% of patients showing improvement and remission rates around 40% of patients completing treatment. These are significant response rates in these serious, hard to treat cases of mood disorders,” added Dr. Kirbat. This is consistent with results at major hospitals and clinics using TMS.

Call Now For a TMS Consultation